A Population Pharmacokinetic-Pharmacogenetic Analysis of AtazanavirKILE, Deidre A; MAWHINNEY, Samantha; AQUILANTE, Christina L et al.AIDS research and human retroviruses. 2012, Vol 28, Num 10, pp 1227-1234, issn 0889-2229, 8 p.Article

Early virologic rebound in a pilottrial of ritonavir-boosted atazanavir as maintenance monotherapyKARLSTRÖM, Olle; JOSEPHSON, Filip; SÖNNERBORG, Anders et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 4, pp 417-422, issn 1525-4135, 6 p.Article

Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavirPHAM, Paul A; FLEXNER, Charles; PARSONS, Teresa et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 2, pp 201-205, issn 1525-4135, 5 p.Article

Simultaneous Population Pharmacokinetic Modelling of Atazanavir and Ritonavir in HIV-Infected Adults and Assessment of Different Dose Reduction StrategiesSCHIPANI, Alessandro; DICKINSON, Laura; BOFFITO, Marta et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 1, pp 60-66, issn 1525-4135, 7 p.Article

Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug MonitoringRODRIGUEZ-NOVOA, Sonia; MORELLO, Judit; BARREIRO, Pablo et al.AIDS research and human retroviruses. 2008, Vol 24, Num 6, pp 821-825, issn 0889-2229, 5 p.Article

Low atazanavir concentrations in cerebrospinal fluidBEST, Brookie M; LETENDRE, Scott L; CAPPARELLI, Edmund V et al.AIDS (London). 2009, Vol 23, Num 1, pp 83-87, issn 0269-9370, 5 p.Article

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive PatientsMALAN, D. R; KRANTZ, Edrich; DAVID, Neal et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 161-167, issn 1525-4135, 7 p.Article

Population Pharmacokinetics of Atazanavir in Human Immunodeficiency Virus-Infected PatientsSOLAS, Caroline; GAGNIEU, Marie-Claude; RAVAUX, Isabelle et al.Therapeutic drug monitoring. 2008, Vol 30, Num 6, pp 670-673, issn 0163-4356, 4 p.Article

Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practiceMOLTO, José; RAMON SANTOS, José; VALLE, Marta et al.Therapeutic drug monitoring. 2007, Vol 29, Num 5, pp 648-651, issn 0163-4356, 4 p.Article

Effects of Oral Posaconazole on the Pharmacokinetics of Atazanavir Alone and With Ritonavir or With Efavirenz in Healthy Adult VolunteersKRISHNA, Gopal; MOTON, A; MA, L et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 4, pp 437-444, issn 1525-4135, 8 p.Article

Efficacy and Safety of Switching From Boosted Lopinavirto Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZI P StudyMALLOLAS, Josep; PODZAMCZER, Daniel; ALBERTO ARRANZ, José et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 1, pp 29-36, issn 1525-4135, 8 p.Article

Clinical outcomes associated with concomitant use of atazanavir and proton pump inhibitorsSAHLOFF, Eric G; DUGGAN, Joan M.The Annals of pharmacotherapy. 2006, Vol 40, Num 10, pp 1731-1736, issn 1060-0280, 6 p.Article

Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 WeeksABERG, Judith A; TEBAS, Pablo; TURNER OVERTON, Edgar et al.AIDS research and human retroviruses. 2012, Vol 28, Num 10, pp 1184-1195, issn 0889-2229, 12 p.Article

Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naïve HIV-1-infected PatientsEDEN, Arvid; ANDERSSON, Lars-Magnus; TUNBÄCK, Petra et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 533-540, issn 0889-2229, 8 p.Article

Efficacy and Safety of Unboosted Atazanavir in Combination with Lamivudine and Didanosine in Naive HIV Type 1 Patients in SenegalLANDMAN, R; DIALLO, M. B; GIRARD, P. M et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 519-525, issn 0889-2229, 7 p.Article

Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV type 1-infected individuals administered different atazanavir dosesBOFFITO, Marta; MAITLAND, Desmond; DICKINSON, Laura et al.AIDS research and human retroviruses. 2006, Vol 22, Num 8, pp 749-756, issn 0889-2229, 8 p.Article

Virological responses to atazanavir-ritonavir-based regimens : resistance-substitutions score and pharmacokinetic parameters (Reyaphar study)PELLEGRIN, Isabelle; BREILH, Dominique; VRAY, Muriel et al.Antiviral therapy (London). 2006, Vol 11, Num 4, pp 421-429, issn 1359-6535, 9 p.Article

Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimensCOLONNO, Richard; ROSE, Ronald; MCLAREN, Colin et al.The Journal of infectious diseases. 2004, Vol 189, Num 10, pp 1802-1810, issn 0022-1899, 9 p.Article

Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients: Randomized, Open-Label Pilot StudyMILLS, Anthony; MILDVAN, Donna; HEERA, Jayvant et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 2, pp 164-170, issn 1525-4135, 7 p.Article

The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytesGIBELLINI, Lara; DE BIASI, Sara; DEPOL, Anto et al.AIDS (London). 2012, Vol 26, Num 16, pp 2017-2026, issn 0269-9370, 10 p.Article

Thermal stability study of the protease inhibitors: Nelfinavir mesylate and atazanavir sulfateMICHALIK, Katarzyna; DRZAZGA, Zofia; MICHNIK, Anna et al.Journal of thermal analysis and calorimetry. 2007, Vol 88, Num 2, pp 401-404, issn 1388-6150, 4 p.Conference Paper

A Randomized Study of Pharmacokinetics, Efficacy, and Safety of 2 Raltegravir Plus Atazanavir Strategies in ART-Treated AdultsCAREY, Dianne; PETT, Sarah L; BLOCH, Mark et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 2, pp 143-149, issn 1525-4135, 7 p.Article

The Pharmacokinetics of Lersivirine (UK-453,061) and HIV-1 Protease Inhibitor Coadministration in Healthy SubjectsVOURVAHIS, Manoli; LANGDON, Grant; LAYTON, Gary et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 1, pp 24-32, issn 1525-4135, 9 p.Article

Atazanavir Pharmacokinetics With and Without Tenofovir During PregnancyMIROCHNICK, Mark; BEST, Brookie M; READ, Jennifer S et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 56, Num 5, pp 412-419, issn 1525-4135, 8 p.Article

The Genotypic Inhibitory Quotient : A Predictive Factor of Atazanavir Response in HIV-1-Infected Treatment-Experienced PatientsSOLAS, Caroline; COLSON, Philippe; RAVAUX, Isabelle et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 2, pp 177-180, issn 1525-4135, 4 p.Article